Lab Corp Drug Development

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:Research_Institute
gptkbp:acquisition gptkb:Covance
gptkbp:clinical_trial gptkb:dictionary
gptkb:healthcare_organization
gptkb:hospital
gptkb:psychologist
gptkb:Gene_Therapy
gptkb:Precision_Medicine
gptkb:Insurance_Company
gptkb:drug
Gastroenterology
Health Economics
Thousands
Transplantation
Urology
Biomarkers
Neurology
Infectious Diseases
Vaccine Development
Endocrinology
Hematology
Dermatology
Phase IV
Phase II
Rare Diseases
Cardiovascular
Phase III
Pharmacogenomics
Autoimmune Disorders
Phase I
Metabolic Disorders
Real-World Evidence
Combination Therapies
Adaptive Trials
Women’s Health
Quality of Life Studies
Patient-Centric Trials
Patient Reported Outcomes
Companion Diagnostics
gptkbp:employees Over 20,000
gptkbp:focus gptkb:Company
Diagnostics
Pharmaceutical Development
gptkbp:founded gptkb:1995
gptkbp:global_presence gptkb:battle
gptkbp:headquarters gptkb:Burlington,_North_Carolina
https://www.w3.org/2000/01/rdf-schema#label Lab Corp Drug Development
gptkbp:parent_company gptkb:Laboratory_Corporation_of_America_Holdings
gptkbp:partnerships Pharmaceutical Companies
Biotech Companies
gptkbp:regulatory_compliance gptkb:FDA
gptkb:EMA
PMDA
gptkbp:services gptkb:Database_Management_System
gptkb:Research_Institute
gptkb:legal_case
Biostatistics
Regulatory Affairs
gptkbp:website www.labcorp.com
gptkbp:bfsParent gptkb:Lab_Corp_Diagnostics
gptkbp:bfsLayer 5